Search Results
Analyzing the ESPAC-5F Trial in Borderline Resectable Pancreatic Cancer
ESPAC-5F: Four arm, prospective, multicentre, international randomised phase II trial of
Approaches to Borderline Resectable/Locally Advanced
Pancreatic Cancer Debate: Optimal Therapy - Preoperative Chemo/Chemoradiotherapy
Borderline resectable pancreatic cancer
Pancreas-Borderline resectable pancreatic cancer
Borderline Resectable Pancreatic Cancer
Preoperative CRT improves overall survival in pancreatic cancer: long-term results of PREOPANC
ESPAC-4: Phase III Trial of Combination Gemcitabine and Capecitabine vs. Gemcitabine...
Borderline Resectable Pancreatic Cancer | Dr. Viraj Lavingia - Program Organizer
Webinar: Neoadjuvant chemotherapy vs upfront surgery for borderline resectable pancreatic cancer
Controversy Debate 1: Is it justified to move from adjuvant to neo-adjuvant treatment? - Yes
